Lisa H. Butterfield, Professor of Medicine, Surgery and Immunology at the University of Pittsburgh and Director of the Immunologic Monitoring and Cellular Products Laboratory (IMCPL) at the University of Pittsburgh Cancer Institute (UPCI), is the President of Society of ImmunoTherapy of Cancer (SITC) and makes for us an assessment of the two days of “Immunotherapy Bridge” congress.
Andare in bici, per un oncologo come me, è una metafora della bellezza e delle difficoltà del nostro lavoro.
